Product Program year 2019 Source: CMS Open Payments

Isatuximab

Drug

Open in the dashboard

General payments

$30,637

29 payments

Research payments

$5,027,366

308 payments

Through program year 2019, $30,637 in general payments and $5,027,366 in research payments were reported against Isatuximab.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $30,637 29
2019 Research $5,027,366 308

Breakdown

Who paid General payments · program year 2019
  1. Sanofi-Aventis U.S. LLC $30,637 29 payments
Top recipients General payments · program year 2019
  1. Raymond Comenzo Hematology & Oncology · Boston, MA $8,690 28% · 4 payments
  2. Joseph Mikhael Hematology · Scottsdale, AZ $5,838 19% · 7 payments
  3. Mansoor Saleh Hematology & Oncology · Sandy Springs, GA $5,200 17% · 7 payments
  4. Sundar Jagannath Medical Oncology · New York, NY $3,584 12% · 2 payments
  5. Ranjana Advani Medical Oncology · Stanford, CA $3,250 11% · 4 payments

The top 5 of 9 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $15,425 50% · 4 practitioners
  2. Medical Oncology Internal Medicine $8,104 26% · 3 practitioners
  3. Hematology Internal Medicine $5,838 19% · 1 practitioner
  4. Internal Medicine $1,270 4% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. Massachusetts $10,047 33% · 3 recipients
  2. Arizona $5,838 19% · 1 recipient
  3. Georgia $5,200 17% · 1 recipient
  4. California $4,520 15% · 2 recipients
  5. New York $3,584 12% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

29 general · 308 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record